Add Company
Join Now

Tegmine Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tegmine Therapeutics's estimated annual revenue is currently $697.5k per year.(i)
  • Tegmine Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Tegmine Therapeutics has 9 Employees.(i)
  • Tegmine Therapeutics grew their employee count by 125% last year.

Tegmine Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder / CEOReveal Email/Phone
2
Scientist IIReveal Email/Phone
3
Bioinformatics Research AssociateReveal Email/Phone
4
Principal ScientistReveal Email/Phone
5
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Tegmine Therapeutics?

Our vision is to restore hope and health for patients diagnosed with untreatable cancers. There have been great advances in cancer therapeutics, but there’s still a lot of progress to be made. At Tegmine, we’ve developed a platform which employs cutting-edge mass spectrometry and CRISPR cell engineering to discover and develop higher-specificity antibody-based therapeutics. Our platform focuses on identifying proteins with tumor-specific modifications that drive disease progression and severity. By targeting proteins in their tumor-promoting state, we are developing high-precision antibodies for the next generation of anti-cancer therapeutics.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$697.5k

Revenue (est)

125%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.2M90%$24.7M
#2
$0.1M9-36%N/A
#3
$7.5M9-18%N/A
#4
$0.7M9N/AN/A
#5
$0.1M9-25%N/A